Is the determination of specific IgE against components using ISAC 112 a reproducible technique?

Rubén Martínez-Aranguren1, María T Lizaso2, María J Goikoetxea1

  • 1Department of Allergology and Clinical Immunology, Clínica Universidad de Navarra, Pamplona, Spain.

Plos One
|February 12, 2014
PubMed

Insights

The ImmunoCAP ISAC 112 assay reliably detects specific IgE to 112 allergens. This fluoro-immunoassay demonstrates good to very good repeatability and reproducibility across different assays, batches, and laboratories for allergy diagnosis.

Area of Science:

  • Allergen immunotherapy
  • Molecular diagnostics
  • In vitro diagnostics

Background:

  • The ImmunoCAP ISAC 112 is a fluoro-immunoassay for detecting specific IgE to 112 molecular components from 51 allergenic sources.
  • Assessing the reliability of diagnostic tools is crucial for accurate clinical decision-making in allergy management.

Purpose of the Study:

  • To evaluate the intra- and inter-assay reliability of the ImmunoCAP ISAC 112.
  • To assess the inter-batch and inter-laboratory reproducibility of the ImmunoCAP ISAC 112 assay.

Main Methods:

  • Twenty samples, including a manufacturer calibrator (CTR02) and sera from 19 polysensitized allergic patients, were analyzed.
  • Intra- and inter-assay variability was assessed by repeating measurements ten times.
  • Inter-batch and inter-laboratory reproducibility were evaluated using two kit batches and two testing laboratories.

Main Results:

  • The CTR02 calibrator showed significant differences from expected values in 8 of 15 allergens.
  • Intra- and inter-assay agreement was very good for 94 allergens.
  • Inter-batch agreement was very good for 82 allergens, and inter-laboratory agreement was very good for 73 allergens.

Conclusions:

  • The ImmunoCAP ISAC 112 is a reliable in vitro diagnostic tool for specific IgE determination.
  • The assay demonstrates good to very good repeatability and reproducibility, supporting its use beyond a single laboratory setting.
Abstract